Emory Pituitary Center

The Emory Pituitary Center offers a multidisciplinary approach to care with a team of pituitary specialists world-renowned for their expertise in the treatment of pituitary adenomas (tumors) and other conditions associated with the pituitary gland. The center provides state-of-the-art diagnostic services in all aspects of endocrinology and neuroradiology and comprehensive therapy for pituitary and hypothalamic disorders, with specialization in neurosurgery, radiation and medical therapy.

Co-directors of the Emory Pituitary Center Nelson Oyesiku, MD, PhD, FACS and Adriana Ioachimescu, MD, PhD partner with a team of specialists who collaborate in the diagnosis, treatment and care of patients with pituitary tumors. In conjunction with the Department of Radiation Therapy, Dr. Oyesiku also offers stereostactic radiosurgery for patients with pituitary lesions. His Laboratory of Molecular Neurosurgery and Biotechnology is a leading center for research in the molecular biology of pituitary tumors.



Experience and Expertise

Emory Pituitary Center has performed over 1,600 pituitary adenoma surgeries. To put this in perspective, most medical centers have performed approximately 300. Emory Pituitary Center also has a tumor bank containing over 600 pituitary specimens and catalogued information about the different types of pituitary disorders.  The Center is working in conjunction with the Emory/Georgia Tech Predictive Health Institute to predict patients' risk of future tumors or health problems by analyzing biomarkers.

Coordinated Care

We understand many pituitary patients have spent years treating symptoms and not the pituitary disorder. In many medical centers, a patient may have to wait weeks between seeing an endocrinologist and a pituitary surgeon or another specialist. Here at Emory, a patient often can see all of the necessary specialists in one visit, when appropriate.

Technology

Emory is one of only four centers in the nation that performs 3-D endoscopic surgical removal of pituitary tumors. The 3-D endoscope offers the ability to see the tumor three-dimensionally, thus enabling the surgeon to remove the tumor in its entirety and minimizing the incidence of errors.

Reputation for Excellence

U.S. News & World Report ranked Emory University Hospital as one of America's Best Hospitals for neurology/neurosurgery five years in row.

Pituitary Research

To reach a research coordinator, please call 404-778-7673 or email to cushingsresearch@emory.edu

Molecular Targeting and Imaging of Pituitary Adenomas, currently enrolling.

A randomized, double-blind, multicenter, phase III study to evaluate the efficacy and safety of pasireotide LAR in patients with Cushing’s disease, currently enrolling

Somatuline Depot (Lanreotide) Injection for Acromegaly: a Post-marketing Observational Study (SODA), multicentric prospective observational study, currently enrolling.

An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease (Seascape), multi-center trial, closed in Aug 2013

Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison with Nonfunctioning Pituitary Tumors, closed in October 2013

Become a Patient